Stocks

Social equity applicants will be prioritized, officials say

CEO Payton Nyquvest says the authorization moves his firm closer to developing medicines at scale to support psychedelic-assisted therapy

The firm could've been immediately on the hook to pay 115% of the principal owed

The firm maintained positive adjusted EBITDA in every quarter last year

Relative category performance is nearly double among Canadians compared to Americans

The Mary Jones brand is set to launch in California by the end of the month

The company says it's well positioned for domestic and international growth

The Netherlands's medical cannabis market is estimated to bring in annual sales of US$80M

The company expects first shipments of its BC-grown cannabis to reach Germany by Q3

The combined company will have 7 cultivation facilities, and expects 40 retail stores in its network by the end of the year

Used in sacred traditions for centuries, the firm says research will bring their medicinal benefits to a larger audience

85% of votes were in favour of consolidating shares to keep the firm's Nasdaq listing

CEO Raj Grover says his firm is on track for continued international growth without reliance on federal legalization in America

But fourth-quarter revenue lagged with a slowdown across its wholesale business

The firm recently signed a deal to sell its products with online vegan marketplace Vejii

The company is also launching a roll-on product for symptom relief

The company says the certification will help boost domestic sales and secure further licensing internationally

The firm says revenues from recurring subscriptions are more reliable than one-time purchases

The firm recorded Q4 revenue of US$320M

As Canadian cannabis retail consolidation picks up steam, CEO Raj Grover says his company has become the 'acquirer of choice'

The firm says its Vancouver locations continue to outperform, where regulatory distancing is more favourable

After a reverse takeover and other business combinations, the firm's CEO says HYTN is on track for future growth

It's the firm's 8th consecutive quarter of positive cash flow from operations

The firm's annual losses reached US$396.1 million

But overall net income tripled to US$2.1M

The deal is in partnership with Hamilton, Ont.-based Noya Cannabis

With a business transition mostly complete, the firm says it expects strong growth in 2022

At full capacity, the firm says it expects to bring in $20M in annual EBITDA

The deal should allow the firm to exit creditor protection and resume public trading

Pineapple Express Delivery will offer the service starting next week

The firm continues to put more emphasis on its beverage alcohol business

If approved, it could advance the firm's goal of becoming a dominant supplier of cannabinoid pharmaceutical ingredients

President Ivan Duque says his country is now at the forefront of regulating commercial exports of medical cannabis

7 new board members will stand for election at a meeting March 8

Company stock hit a 4-year low on Friday

In December, the country became the first to legalize recreational pot in the EU

The funds will go toward developing a treatment for acute respiratory distress syndrome, which can result from Covid-19

The company has also received conditional approval to list on the Canadian Securities Exchange

The stalwart pot firm is projecting a return to EBITDA-positivity later this year, as it pivots to adult-use sales

Job growth in the cannabis sector has averaged over 27% since 2017